BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20236311)

  • 1. Mixed lineage leukemia: roles in human malignancies and potential therapy.
    Marschalek R
    FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.
    Kowarz E; Burmeister T; Lo Nigro L; Jansen MW; Delabesse E; Klingebiel T; Dingermann T; Meyer C; Marschalek R
    Leukemia; 2007 Jun; 21(6):1232-8. PubMed ID: 17410185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
    Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
    Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
    Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
    Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myelogenous leukemia cells with the MLL-ELL translocation convert morphologically and functionally into adherent myofibroblasts.
    Tashiro H; Mizutani-Noguchi M; Shirasaki R; Shirafuji N
    Biochem Biophys Res Commun; 2010 Jan; 391(1):592-7. PubMed ID: 19932689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
    Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
    Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
    He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel AF9 breakpoint in MLL-AF9-positive acute monoblastic leukemia.
    Alonso CN; Longo PL; Gallego MS; Medina A; Felice MS
    Pediatr Blood Cancer; 2008 Apr; 50(4):869-71. PubMed ID: 18000862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15.
    Chinwalla V; Chien A; Odero M; Neilly MB; Zeleznik-Le NJ; Rowley JD
    Oncogene; 2003 Mar; 22(9):1400-10. PubMed ID: 12618766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MLL recombinome of acute leukemias in 2013.
    Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of mixed-lineage leukemia.
    Bach C; Slany RK
    Future Oncol; 2009 Oct; 5(8):1271-81. PubMed ID: 19852741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights to the MLL recombinome of acute leukemias.
    Meyer C; Kowarz E; Hofmann J; Renneville A; Zuna J; Trka J; Ben Abdelali R; Macintyre E; De Braekeleer E; De Braekeleer M; Delabesse E; de Oliveira MP; Cavé H; Clappier E; van Dongen JJ; Balgobind BV; van den Heuvel-Eibrink MM; Beverloo HB; Panzer-Grümayer R; Teigler-Schlegel A; Harbott J; Kjeldsen E; Schnittger S; Koehl U; Gruhn B; Heidenreich O; Chan LC; Yip SF; Krzywinski M; Eckert C; Möricke A; Schrappe M; Alonso CN; Schäfer BW; Krauter J; Lee DA; Zur Stadt U; Te Kronnie G; Sutton R; Izraeli S; Trakhtenbrot L; Lo Nigro L; Tsaur G; Fechina L; Szczepanski T; Strehl S; Ilencikova D; Molkentin M; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
    Leukemia; 2009 Aug; 23(8):1490-9. PubMed ID: 19262598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.